1. Home
  2. XPOF vs KPTI Comparison

XPOF vs KPTI Comparison

Compare XPOF & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xponential Fitness Inc.

XPOF

Xponential Fitness Inc.

HOLD

Current Price

$7.21

Market Cap

211.2M

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.50

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPOF
KPTI
Founded
2017
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.2M
172.6M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
XPOF
KPTI
Price
$7.21
$8.50
Analyst Decision
Hold
Strong Buy
Analyst Count
6
7
Target Price
$8.13
$14.67
AVG Volume (30 Days)
406.2K
1.2M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
35.24
N/A
EPS
N/A
N/A
Revenue
$11,092,000.00
$146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.91
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.57
52 Week Low
$3.83
$3.65
52 Week High
$11.14
$10.99

Technical Indicators

Market Signals
Indicator
XPOF
KPTI
Relative Strength Index (RSI) 58.18 61.64
Support Level $6.81 $5.84
Resistance Level $8.32 $9.00
Average True Range (ATR) 0.42 0.62
MACD 0.08 0.31
Stochastic Oscillator 74.87 88.62

Price Performance

Historical Comparison
XPOF
KPTI

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: